Table 5 Factors linked to complete remission of T2DM 2 years after LSG.
CR n = 86 | No CR n = 140 | p value | OR (95% CI) | |
|---|---|---|---|---|
Age (years) | ||||
≤ 45 | 76 (53.5%) | 66 (46.5%) | < 0.001 | 8.52 (4.07–17.83) |
> 45 | 10 (11.9%) | 74 (88.1%) | 1 | |
Duration of DM | ||||
≤ 5 years | 70 (64.8%) | 38 (35.2%) | < 0.001 | 11.74 (6.08–22.69) |
> 5 years | 16 (13.6%) | 102 (86.4%) | 1 | |
Insulin therapy | ||||
No | 60 (42.9%) | 80 (57.1%) | 0.058 | 1.73 (0.98––3.06) |
Yes | 26 (30.2%) | 60 (69.8%) | 1 | |
No. of oral hypoglycemics | ||||
Single | 36 (69.2%) | 16 (30.8%) | < 0.001 | 5.58 (2.84–10.95) |
Multiple | 50 (28.7%) | 124 (71.3%) | 1 | |
Preoperative BMI | ||||
≤ 40 kg/m2 | 33 (47.8%) | 36 (52.2%) | 0.045 | 1.80 (1.01–3.20) |
> 40 kg/m2 | 53 (33.8%) | 104 (66.2%) | 1 | |
C-peptide (ng/mL) | ||||
> 2.72 | 84 (56.8%) | 64 (43.2%) | < 0.001 | 49.88 (11.80–210.76) |
≤ 2.72 | 2 (2.6%) | 76 (97.4%) | 1 | |
Glycated hemoglobin (%) | ||||
≤ 6.5 | 22 (78.6%) | 6 (21.4%) | < 0.001 | 7.68 (2.97–19.86) |
> 6.5 | 64 (32.3%) | 134 (67.7%) | 1 | |
HOMA-IR | ||||
≤ 4.6 | 76 (67.9%) | 36 (32.1%) | < 0.001 | 21.96 (10.26–45.97) |
> 4.6 | 10 (8.8%) | 104 (91.2%) | 1 | |
